The National Science Foundation (NSF) awarded Space Tango LLC a $274,939 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The grant supports the development of a high-throughput CubeLab platform that will enable nearly 600 individual samples to be studied simultaneously aboard the International Space Station for 30 days. This innovative system will allow Space Tango to collaborate with researchers from institutions like Notre Dame, University of San Diego, Massachusetts General Hospital, and Mount Sinai Icahn School of Medicine on specialized cell studies related to various diseases and health conditions, including Rett syndrome, Alzheimer's disease, cancer, and heart conditions. The grant award, which began on March 1, 2024, aims to leverage the microgravity environment of low-Earth orbit to conduct research that could lead to advancements in healthcare and biomanufacturing.
Generated 12/3/24, 9:25 AM